West Pharmaceutical Services Profit Margin 2006-2018 | WST

Current and historical gross margin, operating margin and net profit margin for West Pharmaceutical Services (WST) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. West Pharmaceutical Services net profit margin as of June 30, 2018 is 8.99%.
West Pharmaceutical Services Annual Profit Margins
West Pharmaceutical Services Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $8.775B $1.599B
West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products. West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines and an emerging leader in the development of advanced formulation technologies for the transmucosal delivery of drugs. West contract manufacturing harnesses a powerful combination of innovation, technology, infrastructure and expertise to serve the pharmaceutical, medical and consumer industries. Along with more than 50 years of experience, they bring customers quality, safety and reliability in injection molding, contract assembly and finished packaging.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $65.366B 23.40
Align Technology (ALGN) United States $26.902B 71.72
McKesson (MCK) United States $26.657B 10.20
AmerisourceBergen (ABC) United States $20.028B 14.56
Laboratory Of America Holdings (LH) United States $17.700B 16.28
Cardinal Health (CAH) United States $15.788B 10.97
Henry Schein (HSIC) United States $13.025B 22.21
Cooper (COO) United States $12.878B 23.19
DENTSPLY SIRONA (XRAY) United States $8.258B 14.45
Merit Medical Systems (MMSI) United States $3.526B 46.35
Patterson (PDCO) United States $2.312B 16.25
CONMED (CNMD) United States $2.121B 35.93
STAAR Surgical (STAA) United States $1.910B 255.65
Atrion (ATRI) United States $1.280B 37.95
Antares Pharma (ATRS) United States $0.556B 0.00
Invacare (IVC) United States $0.488B 0.00
Lifevantage (LFVN) United States $0.154B 21.78
Endologix (ELGX) United States $0.149B 0.00
Aceto (ACET) United States $0.067B 43.80
Pro-Dex (PDEX) United States $0.042B 26.57
Biolase (BIOL) United States $0.028B 0.00
Retractable Technologies (RVP) United States $0.023B 0.00
Milestone Scientific (MLSS) United States $0.022B 0.00